0
0
Read Time:12 Second
The Drugs Controller General of India has approved MSD’s Keytruda (pembrolizumab) in the treatment of triplenegative breast cancer (TNBC) and renal cell carcinoma (RCC) in adults. The approval will address a critical need for select patients, said…